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Abstract 
Various pathophysiological situations of negative energy balance involve the intense depletion 
of body energy reserves. White adipose tissue is a central place to energy storage and a major 
endocrine organ. As a model of choice to better understand how the white adipose tissue 
dynamically responds to changes in substrate availability, we used the prolonged fasting 
paradigm, which is characterized by successive periods of stimulated (phase 2) and then 
reduced (phase 3) lipid mobilization/utilization. Using omics analyses, we report a regulatory 
transcriptional program in rat epididymal adipose tissue favoring lipolysis during phase 2 and 
repressing it during phase 3. Changes in gene expression levels of lipases, lipid droplet-
associated factors, and the proteins involved in cAMP-dependent and cAMP-independent 
regulation of lipolysis were highlighted. The mRNA and circulating levels of adipose-secreted 
factors were consistent with the repression of insulin signalling during prolonged fasting. 
Other molecular responses are discussed, including the regulation of leptin and adiponectin 
levels, the specific changes reflecting an increased fibrinolysis and a possible protein 
catabolism-related energy saving mechanism in late fasting. Finally, few differences between 
internal and subcutaneous adipose tissues are also reported. These data provide a 
comprehensive molecular basis of adipose tissue responses when facing a major energetic 
challenge. 
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Introduction 
Fat tissue is a major regulator of whole-body energy homeostasis (Luo and Liu, 2016). As the 
main energy reservoir, adipose tissue controls the balance between storage and release of 
lipids in response to altered energy intake or expenditure to meet bioenergetics needs. During 
periods of excess energy intake, triglycerides are efficiently deposited into cytosolic droplets, 
which may result in obesity and related diseases. Conversely, triglycerides are hydrolysed 
during times of increased energy demand to release fatty acids to the circulation. Adipose 
tissue is also an important endocrine organ (Bluher and Mantzoros, 2015; Fasshauer and 
Bluher, 2015), producing a number of adipokines/cytokines that regulate overall metabolism, 
insulin sensitivity, endothelial function, hemostasis, and the immune system. In relation to the 
catabolic pathophysiological situations where the level of fat store depletion may greatly 
differ, a better understanding of the adipose molecular response to nutritional and metabolic 
transitions would be helpful to gain insights into the regulation of energy substrate availability. 
Up to now, the molecular mechanisms of adipose tissue have been investigated mainly during 
feeding and short/medium fasting (Bertile et al., 2003; Bertile and Raclot, 2004b; Ding et al., 
2016; Duncan et al., 2007; Duszka et al., 2013; Lafontan and Langin, 2009; Li et al., 2006; Palou 
et al., 2010; Schupp et al., 2013; Sethi and Vidal-Puig, 2007; Viscarra and Ortiz, 2013; L. Yang 
et al., 2011), i.e. in situations where energy metabolism relies mostly on lipid availability. 
During prolonged fasting, however, three sequential metabolic phases have been described 
in humans (Owen et al., 1998), non-hibernating mammals (Bertile and Raclot, 2008), and birds 
(Groscolas and Robin, 2001). The required energy is at first derived from glucose and lipids 
during a short period of adaptation (phase 1), while the net catabolism of body proteins is 
decreased. As the fast duration is increased, energy needs are met mostly from the use of lipid 
fuels during phase 2, while proteins are efficiently spared. Finally, before exhaustion of fat 
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stores, proteins are increasingly used for energy generation during phase 3. Protein 
catabolism is one of the determinants of the safety limit of fasting (Bertile et al., 2016). 
Characterized by successive periods of stimulated and then reduced lipid 
mobilization/utilization, the prolonged fasting paradigm is therefore a good model to gain 
insights into the molecular mechanisms underlying the nutritional regulation of adipose lipid 
metabolism. It is also well known that nutritional transitions can alter the gene expression 
and/or plasma levels of adipose-secreted factors (Bertile and Raclot, 2004a, 2006). In the 
context of the metabolic phases of prolonged fasting, very few studies have analysed the 
expression levels of key adipose metabolic factors providing fuel substrates, neither those of 
secreted proteins acting as bioactive molecules possibly signalling nutritional and/or 
metabolic changes (Bertile and Raclot, 2004a, 2006, 2011; Li et al., 2006). Therefore, further 
research is needed to better assess the molecular regulations that link white adipose tissue to 
fuel partitioning and the level of fat depletion during long term fasting. 
High-throughput technologies, the so-called omics, nowadays have taken front stage in life 
science and medical research to investigate global cellular and molecular responses and better 
understand diseases or pathophysiological situations (Bertile and Raclot, 2008; Manzoni et al., 
2016). The response to short term fasting has already been investigated in different tissues, 
including in white adipose tissue at the transcriptomic (Duszka et al., 2013; Faulconnier et al., 
2011; Ji et al., 2012; Li et al., 2006; Schupp et al., 2013) and proteomic (L. Yang et al., 2011) 
levels. Adipose transcriptome response to prolonged fasting has been described in elephant 
seal pups during prolonged fasting, but their metabolic state, i.e. whether they were in phase 
2 or phase 3, was not assessed (Martinez et al., 2018). Yet, omics data according to the 
metabolic phases of prolonged fasting have only been reported in the rat liver (Wasselin et 
al., 2014) and rat and penguin plasma (Bertile et al., 2009; Bertile et al., 2016). To better 
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understand how the white adipose tissue responds to changes in energy substrate availability 
and gradual levels of fat store depletion, the present study analysed how the adipose 
transcriptome and proteome are affected during prolonged fasting. Specific aims were to 
determine whether i) specific regulation of adipose lipolytic-related factors could be 
responsible for low fat mobilization in the late stage of fasting and ii) regulation of adipose 
secreted factors could help draw hypotheses in relation to the increased drive for refeeding 
in late fasting and/or to possible autocrine/paracrine/endocrine effects contributing to the 
adaptation to food deprivation. As adipose tissue exhibit regional differences in response to 
fasting (Bertile et al., 2003; Bertile and Raclot, 2004a, 2006, 2011; Palou et al., 2010), we 
investigated the response to prolonged food deprivation of visceral and subcutaneous (SC) 
adipose tissues. Finally, because several adipose-derived factors are involved in the control of 
hemostasis, we also explored their levels in the plasma of fed and fasted rats. 
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Results 
Animal metabolic status 
Animal metabolic state was determined using variations in body mass loss and urea circulating 
levels (Table 1; N=8/group). Initial body mass was similar in the three experimental groups. 
Rats in phase 3 of fasting significantly lost more body weight (33%) than rats in phase 2 (23%) 
compared to fed animals (p-value = 0.000015). The utilization of mainly lipid fuels during 
phase 2 of fasting and mobilization of body proteins in phase 3 was reflected in the increase 
of daily rate of body mass loss (dm/m.dt; p-value = 0.028) and plasma urea levels (p-value = 
0.0002) in phase 3 relative to phase 2 of fasting. In addition, mobilization of lipid reserves 
during fasting triggered a significant drop in the mass of epididymal adipose tissue (EPI), which 
was 1.8 times more pronounced in phase 3 than phase 2 of fasting (74% vs. 42%; p-value = 
0.00045). The plasma levels of key metabolites (glucose and fatty acids) and 
hormones/cytokines (NPY, insulin, leptin, TNFα, and adiponectin) connected to our omics data 
were measured here (see below). It is of note that the levels of other plasma metabolites and 
hormones have been reported elsewhere (Bertile and Raclot, 2004a; Bertile et al., 2009; 
Bertile and Raclot, 2011; Wasselin et al., 2014) in similar fed and fasted rats. 
 
Overall EPI adipose tissue transcriptome changes in response to prolonged fasting 
Based on four biological replicates per group, and after elimination of reference genes, 
microarray analysis considered signal intensities from 26788 probes (see Table S1). The signals 
from a total of 11674 probes were differentially expressed between groups (ANOVA p-value 
below 0.05, which corresponded to a false discovery rate [FDR] of 0.078). Thus, a very 
pronounced change of the overall EPI transcriptome was due to fasting. The overlap of probes 
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with changing signals (P <0.05) depending on the group considered revealed that the vast 
majority of them (82%) were differential in phase 3 vs. the fed state, with an approximately 
equivalent number of probe signals being up- and downregulated. Half of the 11674 probes 
exhibited a differential signal in phase 2 vs. the fed state, of which 42% were upregulated and 
58% were downregulated. In addition, half of the 11674 probes also exhibited a differential 
signal in phase 3 vs. phase 2 of fasting, of which 48% were upregulated and 52% were 
downregulated. Because the number of differentially-regulated transcripts was high when 
considering an ANOVA p-value threshold of 0.05, we checked the data by using also a p-value 
threshold of 0.0001. The number of differential signals then dropped to 2870 probes 
(P<0.0001; corresponding to a FDR = 0.008; Figure 1A). Of them, 92% were differential in phase 
3 and 31% in phase 2 vs. the fed state (with ∼2 times more down- than up-regulations). 
Moreover, 34% were differential between fasting stages, with an approximately equivalent 
number of down- and up-regulated genes. Altogether, these results illustrate that changes 
were much more pronounced in phase 3 than in phase 2. 
Hierarchical clustering analyses of genes and arrays were carried out for the set of differential 
probe signals when considering statistical p-values below 0.0001 (Figure 1B). Clustering data 
indicate low variability between biological replicates. Genes were hence successfully 
distinguished between groups, with mRNA expression profiles in fed animals being well 
distinguished from those of fasting stages. 
  
Pathway analysis of EPI adipose tissue transcriptome responses to fasting 
To further investigate the main transcriptomics effects of prolonged fasting, functional 
annotation analysis focused on EPI transcripts that were the most significantly changed (i.e. 
those with p-values below 0.0001) across groups. A total number of 63, 118, and 4 relevant 
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GO terms were found to be significantly enriched when comparing phase 2 to fed, phase 3 to 
fed, and phase 3 to phase 2 animals, respectively (Table S2). These GO terms were distributed 
into several pathways and functions, notably including metabolism, tissue remodelling, the 
endoplasmic reticulum function, and the response to oxidative stress (Figure 1C-E). Apart from 
several broad functions and pathways like fuel metabolism that were significantly affected by 
both fasting stages, we observed that phase 3 triggered specific changes, notably related to 
the response to oxidative stress, angiogenesis, PI3K signalling, and protein metabolism. 
A closer look at the most significant changes (Figure 2A) revealed that, compared to the fed 
state, prolonged fasting significantly decreased the abundance of five transcripts coding 
antioxidant enzymes (up to 3-fold in phase 3 of fasting7), while the abundance of only Gpx3 
and Sqstm1 was increased (2-fold in phase 3). Nineteen EPI transcripts involved in 
carbohydrate metabolism were downregulated by prolonged fasting compared to the fed 
state, in both phase 2 and phase 3 (1.5-14-fold) while only the abundance of Gulo and B3galt1 
was increased (5-18-fold in phase 2 and phase 3). Regarding lipid metabolism, changes were 
globally more marked in phase 3 than in phase 2 of fasting vs. the fed state, with 
downregulation of six lipid synthesis-related transcripts (1.5-5-fold), adiponectin receptor 2 
(Adipor2; 1.4-1.7-fold), and leptin (Lep; 17- and 84-fold in phase 2 and phase 3, respectively). 
On the contrary, EPI transcripts related to fatty acid oxidation were upregulated in fasting vs. 
fed animals (2-17-fold in phase 2 and phase 3; Cpt1a, Acacb, Acsl4). The abundance of 
transcripts coding subunits of the different complexes of the respiratory chain were globally 
decreased by phase 3 of fasting (1.5-3.3-fold). A lot of transcripts related to proteostasis were 
regulated by fasting compared to the fed state, with those involved in protein synthesis 
(chaperones and elongation factors) and those involved in different proteolytic systems 
(calpains, cathepsins, Sqstm1, COP9 signalosome, and Clpp proteases) being either down- or 
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upregulated in phase 2 and especially in phase 3.  It is of note that the abundance of E3 
ubiquitin-ligase TRIM63 (also termed MuRF1) was 87 times higher in phase 3 than in the fed 
state. The other EPI transcripts that were significantly regulated by fasting vs. the fed state 
(more markedly in phase 3 than phase 2) were for example involved in insulin signalling, 
tricarboxylic acid cycle and lactate metabolism. Finally we also noticed fasting-induced 
downregulation of G0s2 and Deptor (2-12-fold in phase 2 and especially in phase 3). 
To further identify biomarkers specific to phase 3 of fasting, we examined in more detail 
expression profiles of changed transcripts (Figure S1). Among biomarkers of metabolic phases 
of fasting, selected on the basis of the magnitude of variation and known functions, phase 3 
was notably characterized by the strong and specific upregulation of argininosuccinate 
synthetase 1 (Ass1) and downregulation of galectin 12 (Lgals12) and the glycerol transporter 
Aqp7.  
 
Regulation of EPI genes associated with lipid metabolism in response to prolonged fasting 
Beyond the overall EPI adipose tissue transcriptome changes in response to prolonged fasting, 
we next focused on lipid metabolism. In accordance with fuel partitioning during prolonged 
fasting, plasma non esterified fatty acids (NEFA) levels were significantly increased in phase 2 
vs. the fed state (2.3-fold), while they were restored to initial values during phase 3 (Figure 
3A). The relative abundance of EPI transcripts that play a role in regulation of lipolysis is 
illustrated in Figure 3A, which is based on the KEGG pathway map rno04923. Regarding the 
main white adipose tissue lipases, ATGL transcript levels were increased (1.5-fold) in phase 2, 
while both HSL and monoglyceride lipase (MGL) transcript levels were decreased in phase 3 
(∼2-fold) relative to the fed state. In addition, the minor monoglyceride lipases abhd6 and 
Abhd12 were upregulated by fasting relative to the fed state, the former in phase 3 (1.5-fold) 
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and the latter in phase 2 (2.2-fold). The fatty acid transport proteins FABP4 and FABPpm, the 
glycerol transport protein (AQP7), as well as lipid droplet-associated proteins (perilipin-1 and 
-2, FSP27, Seipin, Caveolin 1 and 2) were also downregulated especially in phase 3 vs. the fed 
state (∼1.3-10-fold).  
cAMP-dependent protein kinase subunit levels were either unchanged by fasting (PRKACb) or 
downregulated (PRKACa) in both phase 2 and phase 3 of fasting vs. the fed state (1.5-2-fold). 
The regulation of adenylate cyclase depended on the type considered, with downregulation 
of type 3, 5 and 7 in phase 2 and/or phase 3 of fasting vs. the fed state (1.4-2.6-fold) and 
upregulation of type 2 and 4 (1.4 times) in phase 3 and phase 2 of fasting, respectively. 
Adenylate cyclase-stimulating G alpha protein (GNAS) was downregulated by both fasting 
stages compared to the fed state (1.3-1.8-fold) while adenylate cyclase-inhibiting G alpha 
protein GNAI1 was downregulated only in phase 3 (2.2-fold) and GNAI2 and GNAI3 remained 
unchanged. Relative to the fed state, thyrotropin receptor (TSHR) and beta adrenergic 
receptor 3 (ADRB3) transcript levels were decreased only in phase 3 of prolonged fasting (6.3- 
and 2.6-fold, respectively), while the beta adrenergic receptor 2 isoform was upregulated in 
both fasting stages vs. the fed state (1.3-fold). In comparison with the fed state, the adipocyte 
receptors for prostaglandin E2 (PTGER3) and adenosine (ADORA1) were downregulated in 
phase 2 and phase 3 of fasting (1.6-4.2-fold), while the neuropeptide Y receptor type 1 
(NPY1R) was on the contrary upregulated in phase 2 (1.6-fold) and phase 3 of fasting (3.3-
fold). At the plasma level, NPY concentrations were found to significantly decrease in phase 3 
of fasting relative to the fed state (2-fold). 
Among proteins that are known to have an inhibitory effect on ATGL and HSL, G0/G1 switch 
gene 2 (G0S2) was downregulated in phase 2 (1.8-fold) and even more in phase 3 (12-fold) vs. 
the fed state, protein phosphatase-1 subunits were either downregulated in phase 3 (PP1a; 
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1.5-fold) or upregulated by both fasting stages (PP1b; 1.2-1.4-fold), phospholipase C-Related 
Catalytically Inactive Protein (PRIP) was upregulated in phase 2 and phase 3 of fasting (1.4-
1.8-fold), and AMP-activated kinase (AMPK) subunits alpha-2, beta-2 and gamma-1 were 
downregulated in phase 2 and/or phase 3 of prolonged fasting (alpha-2, beta-2, and gamma-
1; 1.3-1.9-fold), whereas the AMPK alpha-1 subunit was increased by both fasting phases vs. 
the fed state (1.9-2.3-fold) and the beta-1 and gamma-2 subunits remained unaffected. We 
also considered the factors that are involved in insulin cAMP-dependent suppression of 
lipolysis. Relative to the fed state, plasma insulin levels were significantly decreased in phase 
2 (2.6-fold), and even more in phase 3 (3.8-fold). The level of its receptor was found to increase 
in response to prolonged fasting in phase2 (2.3-fold) and phase 3 (3.4-fold). The levels of 
insulin receptor substrates 1 and 3 (IRS1/3) remained unchanged, while that of IRS2 was 
increased in both fasting stages (2.3-2.5-fold). Compared to the fed state, most of 
phosphatidyl inositol kinase-3 (PI3K) subunits were downregulated by phase 2 and/or phase 
3 of prolonged fasting (1.2-1.6-fold), with only the alpha subunit being slightly upregulated 
(1.2-fold). Protein kinase B/Akt AKT1 was downregulated only in phase 3 vs. the fed state (1.3-
fold) while AKT2 was downregulated in both phases of prolonged fasting (1.5-3-fold), and 
AKT3 was upregulated at the same time (1.6-1.8-fold). Phosphodiesterase 3B (PDE3B) was also 
transitorily upregulated by fasting in phase 2 vs. the fed state (2.5-fold). 
Glucose and fatty acids taken up from the circulation are main substrates for lipogenesis. 
Circulating glucose levels were gradually decreased by fasting in phase 2 (1.4-fold) and phase 
3 (1.6-fold) vs. the fed state (Figure 3B). The relative abundance across rat groups of EPI 
transcripts that play a role in the regulation of lipogenesis is illustrated in Figure 3B. The CD36 
fatty acid transporter, very long chain acyl-CoA synthase (ACS), long-chain fatty acid-CoA ligase 
isozymes (Acsl3, Acsl4, Acslbg1), perilipin-5 (PLIN5), phosphatidate phosphatase-1 (Lpin1), 
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and fructose-bisphosphate aldolase C (ALDOC) were upregulated by fasting vs. the fed state 
(1.3-13.4-fold). All other lipogenic factors were downregulated in both fasting phases vs. the 
fed state (FASN, GPD1L, GLUT4, Lipin2, DGAT; 1.4-43-fold), or only in phase 2 (Lipin3) or phase 
3 (LPL; 1.2-fold). Compared to the fed state, lipogenesis-related transcription factors CEBP 
alpha and PPAR gamma were also downregulated by phase 3 of fasting (1.7-2.3-fold), while 
RXR gamma was transitorily increased in phase 2 (1.9-fold). 
 
Regulation of EPI genes encoding secreted factors in response to prolonged fasting 
The relative abundance across rat groups of EPI transcripts coding adipose-secreted factors is 
illustrated in Figure 4. Expression levels of most of them remained unchanged during fasting, 
while leptin, retinol-binding protein 4 (RBP4), chemerin (Rarres2), and insulin-like growth 
factor 1 (IGF1) were decreased in phase 2 (1.4-17.3-fold) and even more markedly in phase 3 
of fasting (3-84-fold). Adiponectin (AdipoQ), resistin, adipsin, apelin, and vascular endothelial 
growth factor B (VEGFb) were decreased by fasting only in phase 3 (1.9-4.7-fold). For the other 
changing transcripts of secreted factors, we notably observed an upregulation of 
apolipoprotein E (ApoE), angiopoietin-related protein 4 (ANGPTL4), visfatin and plasminogen 
activator inhibitor 1 (PAI1) in phase 2 (∼2-fold) and phase 3 of prolonged fasting vs. the fed 
state (1.5-4.9-fold). The circulating levels of leptin and TNFα was in line with their adipose 
transcript levels. Indeed, leptinemia strongly dropped in phase 2 vs. the fed state (54-fold), 
and plasma leptin was not detectable in phase 3. Plasma TNFα remained unchanged whatever 
the metabolic phase considered. Changes in adiponectinemia did not reach significance. The 
adiponectin receptor 2 (ADIPOR2) exhibited a decreased expression due to food deprivation 
(1.4-1.7-fold). Finally, the adiponectin receptor 1 (ADIPOR1), tumor necrosis factor receptor 
TNFR1B, IL6 receptor subunit beta, leptin receptor, and type-1A angiotensin II receptor 
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(AGTRA) were upregulated in phase 2 (1.2-1.8-fold) and/or phase 3 of fasting (1.3-2.3-fold) vs. 
the fed state. 
 
EPI and SC adipose tissue proteome changes in response to prolonged fasting 
Investigation of proteome differences between the EPI and SC white adipose tissues of control 
fed rats and of the changes in EPI and SC in response to prolonged fasting was performed 
using quantitative proteomics according to the 2D difference gel electrophoresis (DIGE)/mass 
spectrometry (MS) approach. A total of about 400 proteins spots were nicely detected on 2D 
DIGE gels (Figure S2), of which 8 exhibited a differential (p<0.05) intensity in EPI vs. SC of 
control fed rats (Figure S3), 35 in response to fasting vs. the fed state in EPI (Figure 2B) and 37 
in SC (Figure S3). Functional annotation analysis using Gene Ontology annotations and 
literature examination revealed that differences between EPI and SC in control animals 
involved proteins known to play a role in carbohydrate metabolism (PDHB; two times less 
abundant in SC, p-value = 0.02), the response to oxidative stress (CA5B; 2.5 less abundant in 
SC; p-value = 0.02), nucleotide metabolism (PNP; two times less abundant in SC; p-value = 
0.02), the immune response (TAGLN; 1.6 times more abundant in SC; p-value = 0.01), 
coagulation cascade (FGB and FGG; two times less abundant in SC; p-value = 0.02 and 0.01, 
respectively), protein metabolism (HSPB1; 1.6 times less abundant in SC; p-value = 0.01), and 
vitamin D metabolism (GC; two times less abundant in SC; p-value = 0.03) (Table S3).  
In EPI (Figure 2B), the abundance of proteins known to play a role in the response to oxidative 
stress was significantly decreased during phase 2 (CAT, CA3, and CBR1; two-fold; p-value = 
0.003-0.04) and even more in phase 3 (CAT, CA3, CBR1, and GSTA3; 2-4-fold; p-value = 0.001-
0.04) of fasting compared to the fed state. One antioxidant protein was on the contrary 
upregulated by prolonged fasting vs. the fed state in EPI (PRDX2; 3-3.5-fold; p-value = 0.06 in 
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phase 2 and p-value = 0.02 in phase 3). In addition, EPI proteins involved in carbohydrate 
metabolism (PDHB, GAPDH, ALDOA, PKM, MDH1, and TKT) were downregulated (p-value = 
0.003-0.05) in phase 2 (2.5-5-fold) and even more in phase 3 (2.5-10-fold) relative to the fed 
state. EPI proteins involved in protein synthesis and folding were also downregulated by 
fasting, especially in phase 3 vs. the fed state (TUFM, EF1A1, PDIA3, ERP29, and HSPA8; 2-3-
fold; p-value = 0.02-0.04). Among others, several EPI proteins downregulated by fasting are 
known to be involved in lactate metabolism (LDHB; 2.5-fold in phase 3, p-value = 0.047), the 
mitochondrial respiratory chain (ATP5B, ATP5H; 2-3-fold in phase 2 and phase 3, p-value = 
0.004-0.04), and other metabolic-related pathways (see Table S3). Interestingly, one EPI 
protein involved in lipid metabolism was upregulated in phase 2 of fasting (APOA1; 1.7-fold; 
p-value = 0.02). During prolonged fasting vs. the fed state, we also observed the upregulation 
of an EPI protein that may act as an adipocyte differentiation factor (TAGLN; 5-fold in phase 2 
and phase 3; p-value = 0.01-0.003). 
In SC (Figure S3), prolonged fasting triggered the downregulation of two proteins relative to 
values in the fed state (CA3 and PRDX1; 3-10-fold in phase 2 and phase 3; p-value = 0.01-0.04) 
and the transient upregulation of one protein (GSTM2; 3-fold in phase 2; p-value = 0.03) 
involved in the response to oxidative stress. The abundance of SC proteins involved in 
carbohydrate metabolism was reduced in phase 3 vs. the fed state (TPI1, AKR1B1, ENO1, 
G6PDX, and MDH1; 1.7-14-fold; p-value = 0.02-0.04). SC proteins involved in protein synthesis 
and folding were also downregulated in response to prolonged fasting (P4HB, HSPA5, 
HSP90B1, PDIA3, PDIA6, and PRPF19; 1.5-6-fold in phase 2 and/or phase 3; p-value = 0.0003-
0.048), and the same observation was made for proteolytic-related proteins in phase 3 
(SERPINA1 and PSMC3; 4-5-fold; p-value = 0.02-0.046). The other SC proteins downregulated 
upon fasting vs. the fed state are known to be involved either in lipid metabolism (APOA1, 
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APOA4, CESD1, ANXA6, and SNCG; 2-5-fold in phase 2 and/or phase 3; p-value = 0.003-0.04) 
or in other functions like cell structure or iron transport (see Table S3). 
 
Plasma hemostasis-related factors in response to prolonged fasting 
Among adipose secreted factors, we notably observed changes concerning PAI1 expression in 
response to prolonged fasting (see above), PAI1 being well-known to control hemostasis. To 
gain further insights into fasting-induced changes in hemostasis-related mechanisms, we have 
analysed the plasma proteome from fed and fasted rats. Compared to the fed state, we found 
that the levels of plasma D-dimers were significantly increased by fasting (1.8-fold in phase 3), 
while the levels of fibrinopeptide A (FPA) and of a C-terminal degradation product from the 
fibrinogen α-chain (c-ter FIBA) were significantly decreased (4.8-7.6-fold) in both fasting 
stages (Figure 4; see also Figures S4-S5 and Tables S4). 
 
Validation of EPI omics results using Western-blot analyses 
Western blot results, which are presented in Figure S6, confirmed several of the above 
reported results obtained using proteomics. Fasting-induced decreased levels in EPI carbonic 
anhydrase 3 (CA3) and endoplasmic reticulum resident protein 29 (ERP29) were found here 
to be more pronounced in phase 3 than phase 2 compared to the fed state (1.6-3.7 fold). The 
decrease reported above for protein levels of SC apolipoprotein A-IV (ApoA-IV) and 
endoplamsin (HSP90B1 or GRP94) was found to be also valid in EPI, where the drop was 
especially marked in phase 3 relative to the fed state (3.2-12-fold). However, significance was 
not reached for EPI ApoA-IV due to inter-individual variations. In EPI, the levels of the ApoA-
IV transcript were found to be elevated in phase 3 (see Table S1), which suggests post-
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transcriptional regulations. Finally, complementary to the decreased levels of ATP5B and 
ATP5H subunits of ATP synthase in EPI of fasted rats, no change was observed here regarding 
the levels of the ATP5A1 subunit.  
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Discussion 
Different metabolic phases have been described as the fast duration is extended, with lipid 
fuels (phase 2) and body proteins (phase 3) being successively used as the main source of 
energy. The prolonged fasting paradigm thus offers the opportunity to examine whether the 
adipose tissue responses differ according to fuel partitioning and/or the level of body reserve 
depletion. In the current paper, omics analyses highlighted positive correlations when 
comparing changes in protein versus transcript levels of the 35 entries that were common in 
both datasets. However, relationships were weak when considering changes in phase 2 vs. the 
fed state (r = 0.51 falling to r = 0.2 when removing two exceptional values), changes in phase 
3 vs. the fed state (r = 0.32), and changes in phase 3 vs. phase 2 of fasting (r = 0.04). In prolonged 
fasted rats compared to fed animals, differentially expressed transcripts and proteins highlight the 
same regulated processes/pathways (Figure 2). It was notably interesting to observe that both 
differentially expressed transcripts and proteins that are involved in carbohydrate metabolism and 
oxidative phosphorylation (OXPHOS) were globally downregulated in prolonged fasted rats compared 
to fed animals. Concerning the response to oxidative stress, transcripts were globally up-regulated 
whereas proteins were globally down-regulated. Due the relatively low number of differentially 
expressed proteins, the comparison of changes in transcripts and proteins involved in protein and lipid 
metabolisms is less obvious. As a consequence, we discuss separately hereafter these 
complementary data.  
 
Epididymal adipose tissue lipid metabolism during metabolic phases of prolonged fasting 
Fasting induced a very pronounced change of the omics profiles of adipose tissues. As revealed 
by functional annotation analysis of differential transcripts, lipid metabolism is obviously one 
of the main significantly altered processes in both phases of fasting. Most of lipogenic genes 
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were downregulated by prolonged fasting vs. the fed state, often in more marked manner in 
phase 3 than phase 2, and a high number of lipolytic-related genes were found to be 
differentially expressed in fasted rats according to fuel partitioning. We have previously shown 
that adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) are not coordinately 
regulated in response to changes in fuel partitioning during food deprivation (Bertile and 
Raclot, 2011). Data in the current study nicely accord with these previous results, and bring 
new information suggesting that monoglyceride lipase (MGL) is regulated as HSL is at the 
mRNA level. Among other lipid metabolizing enzymes, the increased mRNA levels of abhd6 in 
phase 3 and of abhd12 in phase 2 could be partly explained by the fact that they function not 
only as monoglyceride lipases, but also as lysophospholipases (Thomas et al., 2014). The action 
of lipases results in the generation of glycerol and fatty acids, which are released into the 
circulation. The decrease in mRNA levels of both the transporter of glycerol (AQP7) and of the 
transporters of fatty acids (FABPs), as well as the drop in NEFA levels during phase 3 of fasting 
vs. the fed state likely reflect low lipolytic rates at this stage.  
A number of lipid droplet-associated proteins are known to modulate the rates of lipolysis 
(Duncan et al., 2007; Lafontan and Langin, 2009). The decrease in perilipin 1 (PLIN1) mRNA 
levels in phase 3 of fasting is in perfect line with previous results (Bertile and Raclot, 2011), 
and may indicate the importance of its transcriptional regulation in controlling lipid availability 
in late fasting. Perilipin2 (PLIN2), also known as adipose differentiation-related protein (ADRP) 
or adipophilin, has recently been reported to enhance lipolysis in adipocytes (Takahashi et al., 
2016). Its increased mRNA levels in phase 3 of fasting could thus contribute, as do ATGL (see 
above), to maintain basal rates of lipolysis for sustaining body needs in lipid substrates in order 
to spare glucose and ketone bodies for other tissue requirements at this stage. ATGL activity 
is also known to be dose-dependently suppressed by G0/G1 switch gene 2 (G0S2) (Schweiger 
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et al., 2012; X. Yang et al., 2010). Accordingly, we show here that the decrease in G0S2 
expression, which has been reported at the protein level during short-term fasting (Zhang et 
al., 2014), is also valid at the mRNA level both in phase 2 and phase 3 of fasting. Finally, 
changes in other lipid droplet-associated proteins, namely cell death activator CIDE-3 (CIDEC 
or FSP27), caveolin-1 and seipin are also expected to reflect mechanisms whereby lipolysis is 
finely tuned during prolonged fasting.  
Regulation pathways of lipolysis in adipocytes include the cAMP, cGMP, and insulin signalling 
pathways, along with the metabolism of arachidonic acid (Fruhbeck et al., 2014; Nielsen et al., 
2014). Our data suggest that the transcriptional control of factors from all of these pathways 
is involved in the response to fuel partitioning during long term food deprivation. Interestingly, 
phospholipase C-related catalytically inactive protein (PRIP) knockout mice exhibit a lean 
phenotype (Yamawaki et al., 2017), which has recently led to conclude that PRIP may be 
involved in the regulation of lipolysis in white adipocytes. The more marked increase in PRIP 
mRNA levels in phase 3 versus phase 2 of fasting could thus contribute to limit lipolysis rates 
in late fasting to values close to basal levels. Finally, among biomarkers differentially-
expressed only in late fasting, changes in galectin-12 (LGALS12) mRNA levels may constitute a 
regulatory step contributing to sustain triacylglycerol mobilization during phase 3, as this 
protein regulates lipolysis, presumably by limiting cAMP levels to downregulate PKA signalling 
(R. Y. Yang et al., 2012). 
 
Epididymal adipose tissue secreted factors during metabolic phases of prolonged fasting 
Adipose tissue is now known to secrete hundreds of proteins, hence playing a role in a number 
of biological processes (Bluher and Mantzoros, 2015; Fasshauer and Bluher, 2015). In the 
current study, several secreted factors involved in lipid metabolism and insulin signalling were 
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the most affected by prolonged fasting. The levels of adiponectin (AdipoQ), resistin, insulin-
like growth factor 1 (IGF1), and leptin transcripts were especially reduced in phase 3. In 
addition, the levels of apolipoprotein E (ApoE) were especially increased in late fasting. These 
data are in very good accordance with previous results obtained with another method in 
similar conditions (Bertile and Raclot, 2004a; Bertile et al., 2009). Here we deepen these data 
by showing that, relative to the fed state, rat plasma adiponectin remains essentially 
unchanged during fasting whatever its duration. Amongst other actions, adiponectin has been 
reported to promote fat storage and reduce lipolysis, although the exact mechanisms are not 
well understood (Tao et al., 2014). The reduced expression levels of ADIPOR2, the main 
adiponectin receptor in adipose tissue, could thus contribute to facilitation of lipolysis and 
reduction of lipogenesis during the two metabolic phases of fasting. The drop in phase 2 
leptinemia was dramatically accentuated in phase 3 so that leptin became undetectable, 
which accords with previous results (Bertile and Raclot, 2004a). In addition, EPI leptin mRNA 
levels dropped in both phase 2 and phase 3 of fasting, independently of the duration of fasting. 
Earlier conclusions that falling leptin levels are likely involved in metabolic adaptation to phase 
3 and in the alarm signal triggering refeeding behaviour in late fasting (Bertile and Raclot, 
2004a, 2006; Bertile et al., 2009), are thus reinforced here. Because leptin is also known to 
exert insulin-sensitizing effects (Blüher, 2013), its gradual reduced levels could favour insulin 
resistance as the duration of fasting increases. Indeed, fasting triggers insulin resistance in 
most mammals, which allows glucose to be spared for the tissues that are unable to oxidize 
lipid fuels like the central nervous system. At the same time, insulinemia is decreased, which 
favours lipolysis (Houser et al., 2013; Martinez and Ortiz, 2017). Here we show that 
insulinemia remains at low levels in both phase 2 and phase 3 of prolonged fasting. 
Interestingly, glucocorticoids promote lipolysis (Djurhuus et al., 2002), and also induce insulin 
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resistance (Purnell et al., 2009). The known rise in corticosteronemia in phase 2 and phase 3 
rats compared to fed animals (Bertile and Raclot, 2004a), could then constitute another 
mechanism favouring lipid fuel mobilization during prolonged fasting. Finally, as it plays a role 
not only in inflammation, but also in insulin secretion by pancreatic β-cells (Revollo et al., 
2007; Sun et al., 2013), increased visfatin mRNA levels in phase 2 and especially phase 3 of 
fasting compared to the fed state, could constitute a first regulatory step towards reduction 
of insulin secretion during prolonged food deprivation.  
 
Epididymal adipose tissue and immunity and angiogenesis during metabolic phases of 
prolonged fasting 
It has been shown that inflammation is triggered by adipose tissue expansion during obesity 
(Reilly and Saltiel, 2017). On the reverse, fasting is known to have beneficial effects on white 
adipose tissue inflammation (Chehimi and Eljaafari, 2017). Here we show that the scheme is 
more complicated since the mRNA levels of important activators of the immune system were 
either increased (TGFb2, IL6st, TNR1B) or decreased (Cxcr2, Dpp4, adipsin, Rbp4) in phase 3 
or remained unchanged throughout the fast (TGFb1, TGFb3, CCL2, MIF, TNFα, IL6). 
Consistently, the circulating levels of TNFα remained very stable across rat groups. Altogether, 
these data suggest that, despite selective changes for activators of the immune system 
reported above, the impact of fasting on white adipose tissue inflammation may not differ 
greatly according to changes in substrate availability and/or the level of adipose store 
depletion. 
Most of angiogenesis-related factors were downregulated at the mRNA level in phase 3 vs. 
the fed state, which could be consistent with the fact that adipose tissue microcirculation is 
less crucial in late fasting as lipid fuels are less mobilized. An alternative explanation could be 
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that a decrease in adipose blood flow lowers the availability of lipid-derived fuel in late fasting, 
thereby indirectly contributing to the rise in protein breakdown of tissues like, e.g., the 
skeletal muscles for sustaining body energy needs. Concerning the VEGF growth factor family, 
only VEGFB mRNA levels were decreased in phase 3 while those of VEGFA and VEGFC 
remained unchanged. Contrary to VEGFB, VEGFA and VEGFC are able to bind to the receptor 
VEGFR-2, which generates stronger signals than VEGFR-1 (Shibuya, 2011). This could help 
sustaining angiogenesis capacity in the microenvironment of adipose tissue in late fasting, 
which could be part of mechanism facilitating basal lipolysis and possibly anticipating 
refeeding to efficiently restore fat reserves.  
 
Epididymal adipose tissue and hemostasis during metabolic phases of prolonged fasting 
Plasminogen activator inhibitor 1 (PAI1) is a multifunctional protein, which is notably able to 
inhibit plasminogen activators (Yasar Yildiz et al., 2014). Thus, the gradual increase of PAI1 
mRNA levels during prolonged fasting compared to the fed state may be involved in the 
reduction of fibrinolysis and could represent a risk of thrombosis and fibrosis on the long term. 
From the peptide mass profiling performed on rat plasma, the sequence of the C-terminal 
degradation product (C-ter FIBA) we identified likely corresponds to the so-called αC domain, 
which is released from fibrinogen upon fibrin formation, and which promotes clot stabilization 
(Collet et al., 2005). In line with the decreased coagulation observed previously in fasting men 
(Muliar et al., 1984), the reduced levels of plasma fibrinopeptide A and fibrinogen αC domain 
we observed here could reflect reduced fibrin formation in phase 2 and phase 3 fasted rats. 
Contrasting data have previously reported an increase of plasmatic fibrinolysis during subtotal 
fasting in healthy subjects, with PAI1 levels remaining unchanged (Huber et al., 2005). D-dimer 
is recognized as a specific end-product derived from plasmin-induced degradation of cross-
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linked fibrin (Soomro et al., 2016). Its increased plasma levels in late fasting, in a context where 
fibrin formation is expected to be reduced (see above), might be involved in the prevention of 
any risk of intravascular coagulation and thrombus formation during prolonged food 
deprivation and it may also help favouring lipid-derived fuel to be delivered to organs.  
Among other biomarkers differentially-expressed only in late fasting, changes in Ass1 levels 
could help white adipose cells to better cope with the lack of dietary Arg and Gln in late fasting 
(Long et al., 2017). The levels of EPI Trim63 (E3 ubiquitin-protein ligase also known as Murf1) 
mRNA rose independently of the duration of fasting, but more markedly in phase 3 than in 
phase 2. As already hypothesized for the E3 ubiquitin ligase COP1 in white and brown 
adipocytes during short term fasting (Nakai et al., 2008; Qi et al., 2006), and provided that 
enhanced Trim63 transcript abundance is translated into higher abundance/activity at the 
protein level, it could be that TRIM63-derived ubiquitination of a variety of adipose proteins 
is required to promote energy savings and regulate lipid metabolism to maintain energy 
homeostasis, especially in late fasting. Finally, annexin 2 (ANXA2) is known to mediate fatty 
acid uptake into adipocytes (Salameh et al., 2016), and the exacerbated decrease in its protein 
level during phase 3 relative to phase 2 may thus favour lipid mobilisation over reesterification 
process in a more marked manner in late fasting.  
 
Regional differences in the response of EPI and SC adipose tissues to prolonged food 
deprivation 
Both EPI and SC adipose tissues were essentially characterized by diminished protein levels, 
with data suggesting lipid trafficking might be more affected in SC, while fasting-induced 
oxidative stress would be more marked and energy production more reduced in internal fat 
pads. Consistently, the metabolic activity of fat pads has been reported to depend on their 
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anatomical location (Kwok et al., 2016). Visceral adipose tissue has been reported to be 
preferentially mobilized over subcutaneous adipose tissue during food restriction, total fasting 
(Bertile and Raclot, 2004b; Sugden et al., 1994; Tang et al., 2017), and even during modest 
weight loss (Chaston and Dixon, 2008). In the current study, very few protein levels differed 
between EPI and SC in fed animals, but responses to fasting highlighted several differences. 
For example, expression levels of two proteins involved in the transport of lipids (ApoA1 and 
ApoA4) and of the CESD1 lipase were lower in SC during fasting, whereas one protein involved 
in lipid transport was more abundant in EPI during fasting (ApoA1). Such differences between 
SC and EPI nicely accord with the preferential mobilization of internal fat pads during food 
deprivation.  
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Conclusion 
The current data highlight a regulatory transcriptional program whereby lipolytic-related 
factors including lipases, lipid droplet-associated and regulating pathway factors appeared 
selectively regulated during metabolic phases of fasting. The gene expression levels of adipose 
secreted factors and their receptors, along with the plasma levels of few of these factors could 
reflect the repression of insulin signalling during prolonged fasting. Leptin and adiponectin 
were highlighted as important factors that could, respectively, favour food behaviour in late 
fasting and control lipid metabolism during both phase 2 and phase 3. Future work 
deciphering post-translational modifications of lipid metabolism-related factors should prove 
useful in complementing the regulation pattern of fasting-responsive pathways. Additionally, 
determining how fasting-induced regulations in white adipose tissues are reversed by 
refeeding, notably after phase 2 versus phase 3 of fasting, would help better manage body 
reserve replenishment in pathophysiological situations. Finally, deciphering the molecular 
responses of oxidative tissues would be helpful to better understand fuel utilization in severely 
undernourished organisms. 
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Materials and methods 
Ethical statement 
The study was conducted in strict accordance with the recommendations stated in the Public 
Health Service policy on Human Care and Use of Laboratory Animals. All experiments were 
performed in conformity with the rules of the European Committee Council Directive of 
November 24, 1986 (86/609/EEC) and the French Department of Agriculture (license no. 67-
226 to T.R.). 
 
Animals and study design 
Twenty-four male Sprague Dawley rats (Janvier CERJ, Le Genest-St-lsle, France) were housed 
individually in a temperature-controlled room (25 ± 1°C), with constant photoperiod (12:12, 
light/dark). They were given free access to water and to a standard diet (UAR A04, 
Villemoisson, France, 50% carbohydrate, 5% fat, and 24% protein, in mass percentage). This 
diet was recommended for rearing laboratory rodents and met National Research Council 
requirements, as certified by the manufacturer. The rats were allowed to acclimatize for 
several days before entering the fasting protocol. They were weighed daily during the whole 
duration of the experiment. Water was supplied ad libitum throughout the experiment for all 
animals. 
When reaching ~280 g, the rats (9-weeks old) were randomly divided into three groups 
(N=8/group). Eight rats were immediately sacrificed as control-fed animals by rapid 
decapitation, without prior anaesthesia (procedure necessary because anaesthesia could 
affect hormone, especially the stress hormone corticosterone, and lipid metabolism). These 
controls rats, which are referred to as fed animals thereafter, were in the postabsorptive state 
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and had a full stomach at the time of sampling. The other rats were fasted until phase 2 (N=8) 
and phase 3 (N=8) of fasting. The rate of body mass loss (dm/m.dt), which is known to reflect 
changes in the rate of protein utilization, was calculated from daily weighing. As phase 2 of 
prolonged fasting is characterized by protein sparing and phase 3 by an increase in body 
protein breakdown, mass loss data enabled us to identify the phase 2/phase 3 transition as 
previously reported (Bertile et al., 2009; Bertile and Raclot, 2011; Cherel et al., 1991; Cherel 
and Le Maho, 1991). The metabolic status of rats was then validated further by plasma 
metabolite and hormone measurements (N=8/group). Although survival is challenged by 
protein wasting during phase 3, this phase has been shown to be reversible provided that food 
availability is restored rapidly (Cherel and Le Maho, 1991). In the present study, phase 3 rats 
were killed ∼1 day after the phase 2–phase 3 transition, i.e. in early phase 3. All animals were 
killed by cervical dislocation between 10 AM and 12 PM. Truncal blood was collected in 
ethylenediaminetetraacetic acid (EDTA) tubes immediately after sacrifice, and plasma was 
separated by centrifugation (1500 g) for 15 min. at 4°C and kept frozen at -80°C until analysis. 
Epididymal (EPI) and inguinal subcutaneous (SC) white adipose tissues were quickly dissected 
from the freshly killed rats and weighed, and then pieces were snap frozen in liquid nitrogen 
and stored at -80°C until analysis.  
 
Plasma metabolite and hormone assays 
The levels of plasma metabolites and hormones were measured in fed and fasted rats  
(N=8/group, except for D-dimer levels where N=6/group). The kits for enzymatic 
determination of plasma urea and glucose were purchased from Sigma Diagnostics (St. Louis, 
MO, USA). Plasma non-esterified fatty acids (NEFA) levels were measured using a kit from 
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Wako Chemicals GmbH (Neuss, Germany), and the turbidimetric determination of cross-linked 
fibrin degradation products (D-dimer) using the D-Dimer PLUS kit from Siemens (Marburg, 
Germany). Commercial ELISA kits were used to measure plasma levels of leptin and 
adiponectin (Alpco Diagnostics; Salem, NH, USA), insulin (Merk Millipore, Molsheim, France), 
NPY (BioSupply, Shipley, UK) and TNFα (Sigma Diagnostics).  
 
Epididymal adipose tissue microarray analysis 
After homogenization of frozen EPI samples (N=4/group) using a laboratory ball mill, total 
RNAs were prepared using the Trizol Reagent, following the manufacturer’s instructions 
(ThermoFisher Scientific). The quantity, quality, and purity of extracted RNA were assessed 
using a NanoDrop 1000 spectrophotometer (NanoDrop, Wilmington, DE, USA) at 260 and 280 
nm and an Agilent 2100 bioanalyser (Agilent, Santa Clara, CA, USA). RNAs were considered 
pure for values of A260/280 ratio > 1.8 and of RNA Integrity Number (RIN) > 9.  
DNA microarray (Affymetrix GeneChip technology) analyses were carried out within the 
IGBMC (Institute of Genetics and Molecular and Cellular Biology, Illkirch, France) Microarray 
and Sequencing platform (http://www-microarrays.u-strasbg.fr/). Four separate hybridization 
sets were performed for the three experimental groups, using the GeneChip Rat Gene 1.0 ST 
array. All assays were performed as per instructions in Affymetrix GeneChip® Whole Transcript 
(WT) Sense Target Labeling Assay Manual (P/N 701880 Rev. 2) 
(http://www.affymetrix.com/support/technical/byproduct.affx?product=raexon-st). 
Microarrays were scanned using an Affymetrix GeneChip Scanner 3000 7G (Affymetrix UK Ltd., 
High Wycombe, UK).  
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Quantification and initial analysis were done using the GeneChip Operating v1.4 (GCOS) and 
Expression Console v1.1 softwares (Affymetrix UK Ltd., High Wycombe, UK). Expression levels 
were calculated using the following parameters: sketch quantile for normalization, Median 
polish as in RMA for summarization. Subsequent analysis was performed on the extended set 
of probesets. Reference genes were eliminated.  
The microarray data obtained in this publication have been deposited in NCBI’s Gene 
Expression Omnibus and are accessible through GEO Series accession number GSE118978 
(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118978). 
 
Epididymal and subcutaneous adipose tissue proteomics analysis  
Methods are detailed in Supplementary materials and methods. Proteomics analysis was 
performed as three different experiments to examine the effects of fasting in EPI (Experiment 
1) and in SC (Experiment 2), and to compare protein profiles in EPI and SC control fed animals 
(Experiment 3). 
After protein extraction, the samples were labelled using a CyDye DIGE Fluor Minimal Dye 
Labeling Kit (GE HealthCare, Uppsala, Sweden) and subjected to isoelectric focusing (IEF) and 
then sodium dodecyl sulfate (SDS)-PAGE electrophoresis. Gel images were acquired using an 
Ettan DIGE Imager (GE HealthCare) at 100 μm resolution, and they were analysed using the 
PDQuestTM 2-D gel analysis software (v8.0.1; BioRad). For EPI (Experiment 1) and SC 
(Experiment 2), intensity values for phase 2 (N = 4) and phase 3 (N = 4) animals were 
normalized to intensities obtained for fed animals (N = 4) which were assigned an arbitrary 
mean value of one. For the comparison of EPI and SC (Experiment 3), SC intensity values (N = 
4) were normalized to intensities obtained in EPI (N = 4) which were assigned an arbitrary 
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mean value of one. After statistical analysis (see below), differential protein spots were 
excised using an automated gel cutter (PROTEINEER sp, Bruker Daltonics, Bremen, Germany) 
and destained. In-gel reduction and alkylation of proteins were then performed using a 
Massprep Station (Waters, MicroMass, Manchester, UK) as previously reported (Plumel et al., 
2014). Proteins were in-gel digested using trypsin (Promega, Madison, WI, USA). The resulting 
peptides were then analysed on a 1200 series nanoHPLC-Chip system (Agilent Technologies, 
Palo Alto, CA, USA) coupled to an HCT™ Plus ion trap (Bruker Daltonics, Bremen, Germany). 
Tandem mass spectrometry (MS/MS) data were analysed using the MascotTM search engine 
(v2.5.1, Matrix Science, London, UK) installed on a local server. Spectra were searched against 
a target-decoy version of the Rattus norvegicus protein database downloaded from Swissprot 
(January 2016, 16118 target + decoy entries) to which common contaminants (e.g. trypsin and 
keratins) were automatically added using the MSDA software suite (Carapito et al., 2014). 
Stringent filtering criteria were applied using Proline software (v1.3; 
http://proline.profiproteomics.fr/) to obtain high confidence identifications (FDR < 1%). 
Single-peptide-based protein identifications, as well as the identification of common 
contaminants such as keratin and trypsin, were not considered. The mass spectrometry 
proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE 
(Vizcaino et al., 2016) partner repository with the dataset identifier PXD010902. 
Among the different proteins that were identified in a given spot, only the major (more 
abundant) ones were considered to be responsible for variations of spot intensities. The 
determination of major proteins was performed following a “peptide counting” strategy: the 
higher the number of peptides assigned to a given protein, the more abundant this protein. 
Here we took into account the fact that tryptic sites are followed or not by a Proline, the 
possible missed cleavages and the adequate size of peptides for their detection by mass 
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spectrometry (i.e. peptides of 7 to 31 amino acids on the basis of our data). Then we compared 
the theoretical number of detectable tryptic peptides to the experimental number we 
identified. The theoretical number of detectable tryptic peptides was similar for major (54 ± 
5) and minor (55 ± 4) proteins in a given gel spot, and major proteins were identified with 
three times more peptides than minor ones (26 ± 2 vs. only 9 ± 1, respectively). 
 
Plasma MS/MS data analysis 
Methods are detailed in Supplementary materials and methods. Briefly, plasma samples 
(N=4/group) were fractionated using a method based on solid phase extraction (SPE). 
Fractions were then spotted onto AnchorChip™ targets (Bruker Daltonics Gmbh, Bremen, 
Germany), and peptide mass profiling was achieved using a matrix-assisted laser desorption-
ionization (MALDI)-time-of-flight (TOF) mass spectrometer (ULTRAFLEXTM, Bruker Daltonics 
Gmbh, Bremen, Germany). After alignment, integration of peak areas and comparison of 
peptide profiles, differential abundant peptides were identified after further fractionation of 
solid phase extraction (SPE) eluted fractions, using a capillary liquid chromatography (LC) 
system (Agilent 1100 series, Wilmington, DE, USA) equipped with a micro fraction collector 
(Agilent 1100 series micro fraction collector, Wilmington, DE, USA). The analysis of proteins 
from complex matrixes like the plasma is a challenging task. To obtain a complete set of 
information, including the detection and identification of differentially abundant 
proteins/peptides together with confirmation of their sequences, different methods were 
used. First LC-ESI-MS/MS of the peptides was performed on an Agilent 1100 Series capillary 
LC system coupled to a HCT™ Plus ion trap (Bruker Daltonics Gmbh, Bremen, Germany). 
Second, direct infusion MS/MS experiments were performed in ESI mode using a HCT™ Plus 
ion trap (Bruker Daltonics Gmbh, Bremen, Germany). Third, analysis in nanoESI mode was 
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done using a Q-Tof-2TM (Waters, Milford, MA, USA) mass spectrometer. Fourth, MALDI-
TOF/TOF experiments were performed on an ULTRAFLEXTM mass spectrometer (Bruker 
Daltonics Gmbh, Bremen, Germany). Fifth, analysis by automated Edman degradation used a 
cLC microsequencer (Applied Biosystems, Foster City, Ca, USA).  
 
Bioinformatics analysis 
Hierarchical clustering was performed using the Cluster v3.0 software (de Hoon et al., 2004). 
Parameters were set as follows: median centering and normalization of genes for adjusting 
data and centroid linkage clustering for both genes and arrays. Dendrograms were generated 
and visualised using the Treeview v1.1.3 program.  
Enrichment and functional annotation analysis of transcriptomics data was performed using 
the desktop version of DAVID (Ease v2.1) and an updated version of Gene Ontology (GO) 
databases (November 2016). Enriched GO terms were filtered by only considering those with 
an Ease score lower than 0.1, a Benjamini p-value lower than 0.05 and a fold enrichment 
higher than 2. Enriched GO terms were grouped together into broad functional categories, 
which were then considered as enriched broad functions. 
 
Statistical analysis 
Statistical analysis was performed using the R software environment v3.0.2 (R Development 
Core Team, 2008). All data are presented as means ± SEM of the indicated number of 
biological replicates. The normal distribution of the measured variables was assessed using 
the Shapiro-Wilk test (p-value > 0.01), and homoscedasticity using the Bartlett test (p-value > 
0.01). Rat characteristics and plasma parameters were compared using ANOVA followed by 
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post-hoc Tukey tests or by Welch Two Sample t-tests when applicable. For EPI (Experiment 
1) and SC (Experiment 2), protein spot intensities between fed and fasted animals were 
compared using ANOVA followed by post-hoc Tukey tests (p-value < 0.05).  Protein spot 
intensities in EPI and SC control animals (Experiment 3) were compared using paired sample 
Student t-tests (p-value < 0.05). For transcriptomics data, significance was considered for 
both ANOVA post-hoc Tukey tests p-values < 0.0001.
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Table 1. Characteristics of fed and fasted rats 
State Fed Phase 2 Phase 3 p-values 
Main fuels Mix1 Lipids Proteins ANOVA P2 vs. fed P3 vs. fed P3 vs. P2 
Rat profiles 
Initial body mass (g) 276.8 ± 1.0 276.6 ± 1.9 278.8 ± 0.8 0.44 0.99 0.54 0.48 
Final body mass (g) - 213.7 ± 3.5 188.1 ± 3.3 - - - 1.2x10-4 
Body mass loss (%) - 22.8 ± 1.0 32.5 ± 1.1 - - - 1.5x10-5 
dm/m.dt (g.100g-1.d-1) - 8.4 ± 0.7 10.3 ± 0.3 - - - 2.8x10-2 
Uremia (mM) 3.8 ± 0.2 5.0 ± 0.4 8.1 ± 0.6 3.0x10-6 0.17 <1.0x10-4 2.0x10-4 
Duration of fasting (d) - 3.0 ± 0.0 5.4 ± 0.2 - - - 3.7x10-6 
White adipose tissue 
EPI mass (g) 2.3 ± 0.1 1.3 ± 0.1 0.6 ± 0.0 5.6x10-9 <1.0x10-4 <1.0x10-4 7.0x10-4 
EPI mass loss (%) - 42.6 ± 6.0 73.9 ± 2.1 - - - 8.8x10-4 
Values are the means ± SEM (n = 8 animals per group). P-values are given for ANOVA, Tukey 
and Welch Two Sample t-tests. P2 and P3: phase 2 and phase 3 of fasting; EPI: epididymal 
adipose tissue. 1 Main fuels include carbohydrates, lipids and proteins. 
  
40 
 
Figure legends 
Figure 1. Overview of EPI transcriptomic response to prolonged fasting in rats 
Differentially abundant epididymal adipose tissue (EPI) transcripts among rat groups (A: P < 
0.0001 for ANOVA and P < 0.05 for Tukey tests; see details in Table S1; N=4/group). Heatmaps 
produced by hierarchical clustering for differential transcripts (B: P < 0.0001 for ANOVA and P 
< 0.05 for Tukey tests; red, black and green boxes: downregulated, intermediate and 
upregulated transcripts, respectively). Functional annotation analysis (see also Tables S1-S2) 
from differential transcripts (C-E; ANOVA p-value<0.0001) among rat groups revealed broad 
functions affected by fasting stages (P2: phase 2; P3: phase 3). ER, Endoplasmic reticulum; 
ECM, extracellular matrix. 
 
Figure 2. Overview of regulated EPI transcripts and proteins in response to prolonged 
fasting in rats 
Differentially expressed epididymal adipose tissue (EPI) transcripts (A: P < 0.0001) and 
proteins (B; P < 0.05) in response to fasting stages (P2: phase 2; P3: phase 3; N=4/group). Grey 
areas cover fold changes in-between -1.5 and 1.5. Orange plain lines (y=x+log2(1.6) and y=x-
log2(1.6)) represent the theoretical curves that would be obtained if regulations in P2 and P3 
vs. the fed state were linear as a function of time (duration of fasting). The farther the 
transcripts or proteins from this line, the more specific their regulation to the metabolic state 
of phase 3. For each protein, corresponding gel spot N° (see Figure S2) is given. Protein 
isoforms identified in several gel spots are underlined. See Table S1 and S3 for details about 
functional categorization of regulated transcripts and proteins.  
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Figure 3. Regulation of EPI lipid metabolism in response to prolonged fasting in rats 
The relative abundance of differentially abundant EPI transcripts among rat groups is shown 
with regard to lipolysis (A) and lipogenesis (B). Colour codes (see legend box) highlight changes 
in response to fasting stages (P2: phase 2; P3: phase 3; N=4/group). For differentially 
expressed proteins (P < 0.05) in P2 or P3 versus the fed state, abundance changes are qualified 
as strong up- or down-regulations when the magnitude of variation is higher than 2-fold, while 
the others are qualified as mild up- or down-regulations. Levels similar to those in the fed state 
are coloured in white, while non-measured factors are coloured in grey. Detailed values can 
be found in Table S1. Few circulating metabolite and hormone levels (in yellow) were also 
assessed (means ± SEM; N=8/group); Bars that do not share the same superscript letter are 
significantly different: P < 0.05 for ANOVA and Tukey tests). AA: Arachidonate; ANP: atrial 
natriuretic peptide; AMP: Adenosine 5’-monophosphate; cAMP: cyclic AMP; Cga/TSHb: 
glycoprotein hormones/thyroid stimulating hormone beta; cGMP: cyclic GMP (Guanosine 
3',5‘-monophosphate); DG: diacylglycerols; G: Glycerol; FA: fatty acids; MG: 
monoacylglycerols; NE/E: norepinephrine/epinephrine; NPY: Neuropeptide Y ; PGE2: 
Prostaglandin E2 ; TG: triacylglycerols. 
 
Figure 4. Regulation of EPI secreted factors in response to prolonged fasting in rats 
The relative abundance of differentially abundant EPI transcripts among rat groups is shown 
with regard to adipose secreted proteins and their receptors. Colour codes (see legend box) 
highlight changes in response to fasting stages (P2: phase 2; P3: phase 3; N=4/group For 
differentially expressed proteins (P < 0.05) in P2 or P3 versus the fed state, abundance changes 
are qualified as strong up- or down-regulations when the magnitude of variation is higher than 
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2-fold, while the others are qualified as mild up- or down-regulations. Levels similar to those 
in the fed state are coloured in white, while non-measured factors are coloured in grey. 
Detailed values can be found in Table S1. Few circulating metabolite and hormone levels 
(N=8/group), as well as hemostatic factors (N=4-6/group), were also assessed (means ± SEM; 
in yellow); Bars that do not share the same superscript letter are significantly different: P < 
0.05 for ANOVA and Tukey tests). FPA: fibrinopeptide A; C-ter FIBA: C-terminal degradation 
product from the fibrinogen α-chain.  
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